An Understanding

At Memorial Sloan Kettering Cancer Center, biopsies from patients now head to a new lab where they are examined to determine whether they house any of 341 genetic mutations, Bloomberg reports. Knowing whether the tumor harbors any of these changes can help guide the patient's treatment, it adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.